Elmezzi Graduate School of Molecular Medicine at Northwell Health, NY, 11030, USA
Translational Brain Research Laboratory, Feinstein Institutes for Medical Research, NY, 11030, USA
Manhasset, New York, United States
Willians Tambo, MD, earned his medical degree from Universidad San Francisco de Quito, Ecuador. As part of his career, Dr. Tambo completed his training at the tertiary level hospital- Hospital de Especialidades Eugenio Espejo, the main hospital across the country. He was involved with Neurosurgery Department assisting as a second or third assistant in the OR. Dr. Tambo also did a sub-internship in Neurosurgery, Infectious Disease, and Neurology at North Shore University Hospital and Long Island Jewish Medical Center at Northwell Health, New York, USA. After graduation, Dr. Tambo was a teaching assistant at the National Board of Medical Examiners (NBME) step 1 in Neuroscience and Clinical Neurology and National Board Exam Qualification for Public Health Ministry. In addition, Dr. Tambo has participated in the Global Health Surgery Program at Northwell Health at Padre Carolo Hospital in Quito, performing many surgeries for benefit of low-income patients. Following these impressive performances, Dr. Tambo joined the Elmezzi Graduate School of Molecular Medicine to pursue a Physician-Scientist program. Currently, Dr. Tambo performs scientific research in Translational Brain Research Laboratory under Dr. Raj Narayan, MD, and Dr. Chunyan Li’s, Ph.D. mentorship. His research focuses on understanding the mechanism of cognitive impairment secondary to neuroinflammation, oxidative stress, and white matter injury after vascular dementia (VaD). He is particularly interested in the neuroprotective mechanism of the Diving Reflex (DR) as a new, non-invasive, non-drug base and endogenous therapy to harness vascular dementia. In his research, Dr. Tambo studies DR-released neuropeptides, such as pituitary adenylate cyclase polypeptide (PACAP) and calcitonin gene-related peptide (CGRP), as key players in increasing cerebral blood flow (CBF), increasing brain tolerance to ischemia, and reducing neurovascular damage after VaD.
Monday, April 24, 2023
11:53am – 12:01pm PST
Disclosure(s): No financial relationships to disclose